Page 145 - D. Cancer biology
P. 145

Suppression of MCF-7 Human Breast Cancer Cell Proliferation
                                 by Globefish Homogenate

                                  Junghoon Kim, and Jungho Kim


        ABSTRACT

    Breast cancer is one of the most aggressive cancers in women worldwide, including in South Korea. Although the treatment of this cancer has improved significantly, it is still the leading cause of
   cancer‐related death in women. Previously, we reported that Globefish homogenate suppresses the growth of human colorectal cancer cells. To extend the applications of Globefish homogenate,
   we investigated its cytotoxic effects on human breast cancer cells. Globefish homogenate was prepared by homogenizing 3-year-old Globefish. To assess the effects of Globefish homogenate on
   growth of MCF-7 human breast cancer cells, cell proliferation and colony formation assays were performed using the cell counting and Crystal Violet staining methods. The 50% inhibitory
   concentration (IC50) of Globefish homogenate on MCF-7 cell proliferation was calculated from the sigmoidal dose-response curve. Additionally, the cytotoxic role of Globefish homogenate was
   confirmed by investigating major signaling pathways using Western blot analysis. The colony formation assay demonstrated that MCF-7 cells treated with Globefish homogenate formed up to
   80% fewer colonies than control MCF-7 cells. Treatment with Globefish homogenate markedly suppressed the growth of MCF-7 cells in a dose-dependent manner. The sensitivity of the cells to
   Globefish homogenate was determined by calculating the IC50; in this case, the IC50 was 210 ug/ml. Furthermore, significant downregulation of Cyclin D1 expression, along with phospho-Akt
   and total Akt levels, was observed in MCF-7 cells treated with Globefish homogenate. This study demonstrates that treatment with Globefish homogenate inhibits the proliferation of MCF-7
   human breast cancer cells by downregulating the expression of phosphor-Akt, total Akt, and Cyclin D1 proteins
         RESULTS
                                                           IC50 of Globefish homogenate on MCF-7 human breast cancer cell proliferation
   Inhibition of Colony forming effect in human breast cancer cells with Globefish Homogenate











   Fig. 1. Inhibition of Colony forming effect in human breast cancer cells with Globefish Homogenate. (A) Crystal violet
   staining of human breast cancer cell MCF at 3and 6day without or with 1% Homogenate. (B) Colony formation was
   reduced with 1% Globe Homogenate, compared to Control at 6day. ** P < 0.01.

    Effects of Globefish homogenate on growth of MCF-7 human breast cancer cells
                                                          Fig. 3. IC50 of Globefish homogenate on MCF-7 human breast cancer cell proliferation. (A)
       A                                                  Representative images of MCF-7 human breast cancer cells with 0%, 0.001%, 0.01%, 0.1%, 1% Globe
                                                          Homogenate at 6days, Phase contrast, X100. (B) IC50 values of Globe Homogenate in MCF7 human
                                                          breast cancer cells. All values are expressed as means ± SD of 3 independent experiments, each done in
                                                          duplicates.
                                                          Downregulation of AKT in MCF7 human breast cancer cell with Globefish homogenate







                B






                                                           Fig. 4. Downregulation of AKT in MCF7 human breast cancer cell with Globefish homogenate. (A) The
                                                           expression of phosphor-S473 Akt, Total Akt, CyclinD1 and loading control ß-actin at without or with 1% Globe
                                                           Homogenate, detected by Western blots. (B) Bar graph shows band density normalized to loading control and
                                                           compared to Control, VersaDoc MP 4000, All values are expressed as means ± SD of 3 independent
    Fig. 2. Effects of Globefish homogenate on growth of MCF-7 human breast cancer cells (A) Representative  experiments, * P <0.05, ** P < 0.01.
    images of MCF7 Growth without or with 1% Globe Homogenate treatment for 6days, Phase contrast, X100.
    Human breast cancer cell MCF7 was plated into 12-well plates at a density of 20000 cells/well. (B) The total
    number of MCF-7 human breast cancer cells without or with 1% Globe homogenate was calculated every other
    day for 6days. ** P < 0.01.
      CONCLUSION
   This study demonstrates that treatment with Globefish homogenate inhibits the proliferation of MCF-7 human breast cancer cells by downregulating the expression of phosphor-Akt, total Akt,
   and Cyclin D1 proteins
      REFERENCES

   Kim J and Kim J. (2018). Inhibitory Effect of Globefish Homogenate on the Growth of Human Colorectal Cancer Cell Lines. KSBB Journal 33, 183-191
    Contact information

   Laboratory of Molecular and Cellular Biology, Department of Life Science, Sogang University, Seoul 40107, Korea
   E-mail : jkim@sogang.ac.kr, Phone: 82-2-715-8461
   140   141   142   143   144   145   146   147   148   149   150